Industry / Malaysia
CCM Duopharma Sales Continue To Grow
May 2009 | Industry Trend AnalysisTo read the full article, please choose one of the following options:
Subcribers please log in
Despite a challenging operating environment, the leading generic drug manufacturer in Malaysia, CCM Duopharma, has released decent financial results. This development underlines BMI's view that pharmaceutical and healthcare firms operating in the South East Asian country are resilient to the global economic

